Buscar
Brainsway Ltd
BWAYAñadir a la lista de seguimiento
15.190USD
-0.100-0.65%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
304.05MCap. mercado
33.12P/E TTM
Más Datos de Brainsway Ltd Compañía
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Información de Brainsway Ltd
Símbolo de cotizaciónBWAY
Nombre de la empresaBrainsway Ltd
Fecha de salida a bolsaDec 24, 2006
Director ejecutivoLevy (Hadar)
Número de empleados120
Tipo de seguridadDepository Receipt
Fin del año fiscalDec 24
Dirección16 Hartum Street Rad Tower, 14Th Floor
CiudadJERUSALEM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal9777516
Teléfono97225813140
Sitio Webhttps://www.brainsway.com/
Símbolo de cotizaciónBWAY
Fecha de salida a bolsaDec 24, 2006
Director ejecutivoLevy (Hadar)
Ejecutivos de Brainsway Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Prof. Abraham Zangen, Ph.D.
Prof. Abraham Zangen, Ph.D.
Director
Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Brainsway Ltd?
Los cinco principales accionistas de Brainsway Ltd son: Dr. David Zacut, M.D.
¿Cuántas instituciones poseen acciones de Brainsway Ltd (BWAY)?
A fecha de 2026Q1, 95 instituciones poseen acciones de Brainsway Ltd, con un valor de mercado combinado de aproximadamente 12.27M, lo que representa el 30.66% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -3188785.00.